L'Oréal

L'Oreal increased sales in the third quarter by almost 12 percent to €11.56 billion; adjusted and like‑for‑like revenues grew by 7.7 percent. Drivers were mainly fine fragrances, hair care and online sales, and the group also reported progress in the important skincare category. The stock rose in after‑hours trading, analysts praised the strong quarter, and profit figures were not disclosed as usual. » More on finanzen.net

Jefferies has confirmed its 'Hold' rating for L'Oreal and left the target price at €361. Analyst David Hayes called the cosmetics maker's quarterly report impressive. The stock is highly valued, but that valuation appears justified. » More on finanzen.net

L'Oreal increased sales in the third quarter by almost 12% year-on-year to €11.56 billion; on a like-for-like and comparable basis revenues grew by 7.7%. Growth was driven mainly by perfumery and haircare, and according to CEO Nicolas Hieronimus the company now also outperforms in the important skincare category. Online sales supported the performance, and ADRs rose by more than 4%. No profit figures were provided at the time of the quarter. » More on finanzen.net

Arizona’s attorney general has filed suit against L’Oreal, accusing the company of hiding evidence that hair-straightening products can cause ovarian and uterine cancer. The lawsuit alleges L’Oreal sold products—used predominantly by women of African descent—without warning labels, violating consumer protection laws. Arizona seeks fines, damages and a court order banning sales without warnings. L’Oreal already faces more than 12,000 similar lawsuits consolidated in a multidistrict litigation in Chicago. » More on de.investing.com

Barclays sees L’Oreal as the main beneficiary of the selective beauty market, where brand strength and innovation determine winners. Positive H1 results from Puig indicate continued demand in the premium and luxury segments, with fragrances and make-up remaining dynamic and dermocosmetics gaining market share. According to Barclays, L’Oreal scores particularly in dermocosmetics and records around 7% growth in the US and Europe, along with strong APAC growth. Recent developments: an exclusive 50‑year beauty license with Gucci (first products in 2028) and an analyst upgrade due to good inflation management. » More on de.investing.com